Variant report
Variant | esv3353093 |
---|---|
Chromosome Location | chr5:68925196-68944094 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:181)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:6)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BATF | chr5:68943296-68943561 | GM12878 | blood: | n/a | n/a |
2 | BATF | chr5:68943262-68943564 | GM12878 | blood: | n/a | n/a |
3 | BCL11A | chr5:68929807-68929986 | GM12878 | blood: | n/a | n/a |
4 | BCL11A | chr5:68943300-68943528 | GM12878 | blood: | n/a | n/a |
5 | BCL11A | chr5:68938155-68938433 | GM12878 | blood: | n/a | n/a |
6 | BCL11A | chr5:68938631-68938850 | GM12878 | blood: | n/a | n/a |
7 | BCL11A | chr5:68943264-68943493 | GM12878 | blood: | n/a | n/a |
8 | CEBPB | chr5:68926064-68926713 | K562 | blood: | n/a | n/a |
9 | CEBPB | chr5:68926177-68926302 | K562 | blood: | n/a | n/a |
10 | CEBPD | chr5:68926047-68926457 | K562 | blood: | n/a | n/a |
11 | CTCF | chr5:68926100-68926287 | K562 | blood: | n/a | n/a |
12 | CTCF | chr5:68941755-68941967 | K562 | blood: | n/a | n/a |
13 | CTCF | chr5:68926017-68926364 | K562 | blood: | n/a | n/a |
14 | CTCF | chr5:68926080-68926230 | GM12865 | blood: | n/a | n/a |
15 | CTCF | chr5:68941798-68942090 | K562 | blood: | n/a | n/a |
16 | CTCF | chr5:68926021-68926381 | K562 | blood: | n/a | n/a |
17 | CTCF | chr5:68941643-68942035 | K562 | blood: | n/a | n/a |
18 | CTCF | chr5:68929341-68929391 | Kidney_OC | kidney: | n/a | n/a |
19 | EBF1 | chr5:68928679-68928891 | GM12878 | blood: | n/a | n/a |
20 | EBF1 | chr5:68943225-68943567 | GM12878 | blood: | n/a | n/a |
21 | EBF1 | chr5:68935923-68936117 | GM12878 | blood: | n/a | n/a |
22 | EBF1 | chr5:68938657-68938868 | GM12878 | blood: | n/a | n/a |
23 | EBF1 | chr5:68943268-68943562 | GM12878 | blood: | n/a | n/a |
24 | EP300 | chr5:68936727-68936969 | GM12878 | blood: | n/a | n/a |
25 | EP300 | chr5:68938614-68938856 | GM12878 | blood: | n/a | n/a |
26 | FOSL2 | chr5:68929549-68929799 | HepG2 | liver: | n/a | n/a |
27 | FOSL2 | chr5:68938557-68938850 | HepG2 | liver: | n/a | n/a |
28 | FOSL2 | chr5:68935920-68936184 | HepG2 | liver: | n/a | n/a |
29 | FOXA2 | chr5:68939225-68939877 | A549 | lung: | n/a | n/a |
30 | FOXP2 | chr5:68940199-68940644 | PFSK-1 | brain: | n/a | n/a |
31 | FOXP2 | chr5:68929029-68929480 | PFSK-1 | brain: | n/a | n/a |
32 | FOXP2 | chr5:68929790-68930211 | PFSK-1 | brain: | n/a | n/a |
33 | FOXP2 | chr5:68930535-68930850 | PFSK-1 | brain: | n/a | n/a |
34 | GABPA | chr5:68929546-68929739 | Hela-S3 | cervix: | n/a | n/a |
35 | GABPA | chr5:68925837-68925961 | Hela-S3 | cervix: | n/a | n/a |
36 | GABPA | chr5:68930033-68930246 | Hela-S3 | cervix: | n/a | n/a |
37 | GABPA | chr5:68930007-68930160 | Hela-S3 | cervix: | n/a | n/a |
38 | GABPA | chr5:68930359-68930595 | Hela-S3 | cervix: | n/a | n/a |
39 | GABPA | chr5:68936741-68937001 | Hela-S3 | cervix: | n/a | n/a |
40 | GABPA | chr5:68936017-68936150 | Hela-S3 | cervix: | n/a | n/a |
41 | GABPA | chr5:68929617-68929721 | Hela-S3 | cervix: | n/a | n/a |
42 | GATA2 | chr5:68942317-68942526 | K562 | blood: | n/a | n/a |
43 | GATA2 | chr5:68943211-68943516 | K562 | blood: | n/a | n/a |
44 | GATA2 | chr5:68943732-68944022 | K562 | blood: | n/a | n/a |
45 | GATA2 | chr5:68941845-68942084 | K562 | blood: | n/a | n/a |
46 | GATA2 | chr5:68938604-68938844 | K562 | blood: | n/a | chr5:68938767-68938777 |
47 | IRF4 | chr5:68935831-68936202 | GM12878 | blood: | n/a | n/a |
48 | JUND | chr5:68930384-68930620 | HepG2 | liver: | n/a | n/a |
49 | JUND | chr5:68935924-68936103 | HepG2 | liver: | n/a | n/a |
50 | JUND | chr5:68938128-68938271 | HepG2 | liver: | n/a | n/a |
No data |
No data |
(count:6 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-TAF9-2 | chr5:68932196-68933063 | ENSG00000250552 |
2 | lnc-TAF9-6 | chr5:68938032-68938116 | NONHSAT101933 |
3 | lnc-TAF9-6 | chr5:68941709-68941896 | NONHSAT101933 |
4 | lnc-TAF9-6 | chr5:68933825-68933923 | NONHSAT101936 |
5 | lnc-TAF9-6 | chr5:68936019-68936193 | NONHSAT101933 |
6 | lnc-TAF9-6 | chr5:68936019-68938008 | NONHSAT101936 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000248769 | TF binding region |
ENSG00000250138 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs374414458 | chr5:68925805-68925806 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs376022284 | chr5:68925920-68925921 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs370266595 | chr5:68926055-68926056 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs201733573 | chr5:68927608-68927609 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs367926259 | chr5:68927623-68927624 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs570743173 | chr5:68927655-68927656 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs538065674 | chr5:68927664-68927665 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs79147590 | chr5:68927676-68927677 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs374188899 | chr5:68927693-68927694 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs368904163 | chr5:68927701-68927702 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs568202620 | chr5:68927712-68927713 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs372166417 | chr5:68927743-68927744 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs78541768 | chr5:68927746-68927747 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs535547476 | chr5:68927766-68927767 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs553541293 | chr5:68927768-68927769 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs201031170 | chr5:68927841-68927842 | Enhancers Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs201967684 | chr5:68927845-68927846 | Enhancers Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs572031548 | chr5:68927863-68927864 | Enhancers Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs545449469 | chr5:68927872-68927873 | Enhancers Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs558066832 | chr5:68927978-68927979 | Enhancers Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs375884043 | chr5:68927988-68927989 | Enhancers Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs576308900 | chr5:68927989-68927990 | Enhancers Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs201046606 | chr5:68928280-68928281 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs371303501 | chr5:68928365-68928366 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs543646389 | chr5:68928420-68928421 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs62374275 | chr5:68928433-68928434 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs561953661 | chr5:68928501-68928502 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs200108570 | chr5:68928609-68928610 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs201118284 | chr5:68928618-68928619 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs202054364 | chr5:68928678-68928679 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs529417586 | chr5:68928683-68928684 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs200309676 | chr5:68928699-68928700 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs373173173 | chr5:68928711-68928712 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs375465564 | chr5:68928712-68928713 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs80104476 | chr5:68928734-68928735 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs541535307 | chr5:68928763-68928764 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs200177040 | chr5:68928780-68928781 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs559552701 | chr5:68928787-68928788 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs533397752 | chr5:68928801-68928802 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs551777741 | chr5:68928826-68928827 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs570808196 | chr5:68928835-68928836 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs377495071 | chr5:68928930-68928931 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs370395111 | chr5:68928931-68928932 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs202120351 | chr5:68928934-68928935 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs200447535 | chr5:68929006-68929007 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs201113383 | chr5:68929009-68929010 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs200967433 | chr5:68929011-68929012 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs200704023 | chr5:68929013-68929014 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs377581375 | chr5:68929078-68929079 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs201180084 | chr5:68929117-68929118 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Ovarian cancer | 21781307 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 22032731 | CNVD |
Prostate cancer | 21965145 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Oral cancer | 21386901 | CNVD |
Bladder cancer | 21909424 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 19602461 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
abnormal development | 18461090 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Breast cancer | 21045282 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Myelodysplastic syndrome | 18663149 | CNVD |
Spinal muscular atrophy | 15981080 | CNVD |
Spinal muscular atrophy | 18839960 | CNVD |
Spinal muscular atrophy | 19716110 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 21990379 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Apoptosis | 19488400 | CNVD |
Breast cancer | 22048815 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Colorectal cancer | 20459617 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Spinal muscular atrophy | 17160897 | CNVD |
Spinal muscular atrophy | 17668391 | CNVD |
Spinal muscular atrophy | 17668395 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Prostate cancer | 16461572 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Pseudo-TORCH syndrome | 20727516 | CNVD |
Breast cancer | 22522925 | CNVD |
Autism | 21865298 | CNVD |
Medullary thyroid carcinoma | 18765511 | CNVD |
Obesity | 21131291 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Breast cancer | 21364760 | CNVD |
Disease | 19212409 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:68922800-68927600 | Weak transcription | Primary neutrophils fromperipheralblood | blood |
2 | chr5:68926600-68929000 | Weak transcription | Primary monocytes fromperipheralblood | blood |
3 | chr5:68926600-68929000 | Weak transcription | Primary T cells from cord blood | blood |
4 | chr5:68926600-68929000 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
5 | chr5:68926600-68929000 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
6 | chr5:68926600-68929000 | Weak transcription | Primary mononuclear cells fromperipheralblood | Blood |
7 | chr5:68926600-68929000 | Weak transcription | Brain Germinal Matrix | brain |
8 | chr5:68926600-68929000 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
9 | chr5:68926600-68929000 | Weak transcription | Fetal Intestine Large | intestine |
10 | chr5:68926600-68929000 | Weak transcription | Fetal Intestine Small | intestine |
11 | chr5:68926600-68929000 | Weak transcription | Fetal Stomach | stomach |
12 | chr5:68926600-68929000 | Weak transcription | Ovary | ovary |
13 | chr5:68927000-68927800 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
14 | chr5:68927600-68928200 | Strong transcription | Primary neutrophils fromperipheralblood | blood |
15 | chr5:68927800-68928000 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
16 | chr5:68927800-68928000 | Enhancers | Brain Anterior Caudate | brain |
17 | chr5:68928000-68928200 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
18 | chr5:68928200-68929800 | Weak transcription | Primary neutrophils fromperipheralblood | blood |